ARCHIVES

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

This article is from The Cancer Letter archive.

Vol. 32 No. 26 | July 7, 2006

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

National Breast Cancer Coalition Sets Goal To End Breast Cancer By Jan. 1, 2020

September 24, 2010

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005